DMAC
DiaMedica Therapeutics Inc.
Company overview
- Market capitalization
- $448.66M
- Employees
- 35
- Latest publication
- 2026-09-29
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | -27,999USD | 0USD | 0USD | 0USD | 13,802,000USD | 0USD | 0USD |
| Cost Of Revenue | 11,000USD | 13,999USD | 18,000USD | 3,000USD | 11,000USD | 11,000USD | 6,883,000USD | 10,000USD |
| Gross Profit | -11,000USD | -13,999USD | -18,000USD | -3,000USD | -11,000USD | -11,000USD | -6,883,000USD | -10,000USD |
| Research Development | 7,987,000USD | 6,699,000USD | 6,437,000USD | 5,822,000USD | 5,656,000USD | 6,470,000USD | 4,983,000USD | 3,928,000USD |
| Selling General Administrative | 2,495,000USD | 2,514,000USD | 2,596,000USD | 2,185,000USD | 2,488,000USD | 1,949,000USD | 1,900,000USD | 1,710,000USD |
| Total Operating Expenses | 10,482,000USD | 9,213,000USD | 9,033,000USD | 8,007,000USD | 8,144,000USD | 8,419,000USD | 6,883,000USD | 5,638,000USD |
| Operating Income | -10,482,000USD | -9,213,000USD | -9,033,000USD | -8,007,000USD | -8,144,000USD | -8,419,000USD | -6,883,000USD | -5,638,000USD |
| Income Before Tax | -10,035,000USD | -8,730,000USD | -8,614,000USD | -7,693,000USD | -7,701,000USD | -7,891,000USD | -6,267,000USD | -5,112,000USD |
| Income Tax Expense | -7,000USD | 10,000USD | 6,000USD | 6,000USD | 6,000USD | 9,000USD | 7,000USD | 7,000USD |
| Tax Provision | 7,000USD | 10,000USD | 6,000USD | 6,000USD | 6,000USD | 9,000USD | 7,000USD | 7,000USD |
| Net Income | -10,042,000USD | -8,740,000USD | -8,620,000USD | -7,699,000USD | -7,707,000USD | -7,900,000USD | -6,274,000USD | -5,119,000USD |
| Net Income From Continuing Ops | -10,042,000USD | -8,740,000USD | -8,620,000USD | -7,699,000USD | -7,707,000USD | -7,900,000USD | -6,274,000USD | -5,119,000USD |
| Ebit | -10,482,000USD | -9,213,000USD | -9,033,000USD | -8,007,000USD | -8,144,000USD | -7,891,000USD | -6,883,000USD | -5,638,000USD |
| Ebitda | -10,471,000USD | -9,202,000USD | -9,015,000USD | -8,004,000USD | -8,133,000USD | -7,880,000USD | -6,873,000USD | -5,628,000USD |
| Depreciation And Amortization | 11,000USD | 11,000USD | 18,000USD | 3,000USD | 11,000USD | 11,000USD | 10,000USD | 10,000USD |
| Reconciled Depreciation | 11,000USD | 11,000USD | 18,000USD | 3,000USD | 11,000USD | 11,000USD | 10,000USD | 10,000USD |
| Total Other Income Expense Net | 447,000USD | 483,000USD | 419,000USD | 314,000USD | 443,000USD | 528,000USD | 616,000USD | 526,000USD |
| Selling And Marketing Expenses | — | — | — | — | 45,000USD | — | — | 10,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 500,000USD |
| Research Development | 24,614,000USD | 19,057,000USD | 13,110,000USD | 7,839,000USD | 8,765,000USD | 8,205,000USD | 7,900,000USD | 4,522,000USD |
| Selling General Administrative | 9,783,000USD | 7,624,000USD | 8,157,000USD | 6,162,000USD | 4,881,000USD | 4,494,000USD | 3,693,000USD | 2,739,000USD |
| Total Operating Expenses | 34,397,000USD | 26,681,000USD | 21,267,000USD | 14,001,000USD | 13,646,000USD | 12,699,000USD | 11,593,000USD | 7,261,000USD |
| Operating Income | -34,397,000USD | -26,681,000USD | -21,267,000USD | -14,001,000USD | -13,646,000USD | -12,699,000USD | -11,593,000USD | -6,761,000USD |
| Income Before Tax | -32,738,000USD | -24,414,000USD | -19,338,000USD | -13,648,000USD | -13,564,000USD | -12,265,000USD | -10,618,000USD | -5,654,000USD |
| Income Tax Expense | 28,000USD | 30,000USD | 43,000USD | 28,000USD | 28,000USD | 27,000USD | 31,000USD | 80,000USD |
| Tax Provision | 28,000USD | 30,000USD | 28,000USD | 28,000USD | 28,000USD | 27,000USD | 31,000USD | 80,000USD |
| Net Income | -32,766,000USD | -24,444,000USD | -19,381,000USD | -13,676,000USD | -13,592,000USD | -12,292,000USD | -10,649,000USD | -5,734,000USD |
| Net Income From Continuing Ops | -32,766,000USD | -24,444,000USD | -17,971,000USD | -13,676,000USD | -13,592,000USD | -12,292,000USD | -10,649,000USD | -5,734,000USD |
| Ebit | -34,397,000USD | -26,681,000USD | -21,267,000USD | -14,001,000USD | -13,646,000USD | -12,699,000USD | -11,593,000USD | -5,654,000USD |
| Ebitda | -34,354,000USD | -26,642,000USD | -21,237,000USD | -13,976,000USD | -13,622,000USD | -12,678,000USD | -11,572,000USD | -5,639,000USD |
| Depreciation And Amortization | 43,000USD | 39,000USD | 30,000USD | 25,000USD | 24,000USD | 21,000USD | 21,000USD | 15,000USD |
| Reconciled Depreciation | 43,000USD | 39,000USD | 28,000USD | 25,000USD | 24,000USD | 21,000USD | 21,000USD | 15,000USD |
| Total Other Income Expense Net | 1,659,000USD | 2,267,000USD | 1,929,000USD | 353,000USD | 82,000USD | 434,000USD | 975,000USD | 747,000USD |
| Cost Of Revenue | — | 39,000USD | 30,000USD | 25,000USD | 24,000USD | 21,000USD | 21,000USD | 0USD |
| Gross Profit | — | -39,000USD | -30,000USD | -25,000USD | -24,000USD | -21,000USD | -21,000USD | 500,000USD |
| Selling And Marketing Expenses | — | 193,000USD | 196,000USD | 103,000USD | — | — | — | — |
| Interest Expense | — | — | — | 353,000USD | 82,000USD | 229,000USD | 119,000USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | — | -13,592,000USD | -12,292,000USD | -10,649,000USD | -5,734,000USD |
| Non Operating Income Net Other | — | — | — | — | — | 434,000USD | 975,000USD | 1,107,000USD |
| Interest Income | — | — | — | — | — | — | — | 39,000USD |
| Minority Interest | — | — | — | — | — | — | — | 0USD |
| Discontinued Operations | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 53,080,000USD | 61,371,000USD | 57,047,000USD | 31,470,000USD | 38,830,000USD | 46,345,000USD | 52,524,000USD | 56,791,000USD |
| Other Current Assets | 1,032,000USD | 481,000USD | 645,000USD | 880,000USD | 849,000USD | 227,000USD | 280,000USD | 568,000USD |
| Total Liab | 5,845,000USD | 5,260,000USD | 5,425,000USD | 4,300,000USD | 4,876,000USD | 5,627,000USD | 4,560,000USD | 3,376,000USD |
| Total Stockholder Equity | 47,235,000USD | 56,111,000USD | 51,622,000USD | 27,170,000USD | 33,954,000USD | 40,718,000USD | 47,964,000USD | 53,415,000USD |
| Other Current Liab | 2,340,000USD | 3,545,000USD | 3,239,000USD | 2,747,000USD | 3,053,000USD | 4,347,000USD | 3,024,000USD | 2,229,000USD |
| Capital Stock | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Retained Earnings | -182,810,000USD | -172,768,000USD | -164,028,000USD | -155,408,000USD | -147,709,000USD | -140,002,000USD | -132,102,000USD | -125,828,000USD |
| Cash | 4,868,000USD | 15,647,000USD | 3,326,000USD | 4,109,000USD | 2,589,000USD | 3,025,000USD | 4,134,000USD | 14,066,000USD |
| Cash And Short Term Investments | 51,331,000USD | 59,890,000USD | 55,318,000USD | 30,038,000USD | 36,320,000USD | 44,147,000USD | 50,197,000USD | 54,055,000USD |
| Total Current Assets | 52,363,000USD | 60,629,000USD | 56,223,000USD | 31,079,000USD | 37,422,000USD | 44,610,000USD | 50,767,000USD | 55,014,000USD |
| Total Current Liabilities | 5,748,000USD | 5,132,000USD | 5,268,000USD | 4,116,000USD | 4,665,000USD | 5,390,000USD | 4,297,000USD | 3,088,000USD |
| Net Debt | -4,656,000USD | -15,407,000USD | -3,060,000USD | -3,817,000USD | -2,273,000USD | -2,685,000USD | -3,769,000USD | -13,678,000USD |
| Short Term Debt | 115,000USD | 112,000USD | 109,000USD | 108,000USD | 105,000USD | 103,000USD | 102,000USD | 100,000USD |
| Short Long Term Debt Total | 212,000USD | 240,000USD | 266,000USD | 292,000USD | 316,000USD | 340,000USD | 365,000USD | 388,000USD |
| Short Term Investments | 46,463,000USD | 44,243,000USD | 51,992,000USD | 25,929,000USD | 33,731,000USD | 41,122,000USD | 46,063,000USD | 39,989,000USD |
| Net Receivables | 16,000USD | 258,000USD | 260,000USD | 161,000USD | 253,000USD | 236,000USD | 290,000USD | 391,000USD |
| Accounts Payable | 3,293,000USD | 1,475,000USD | 1,920,000USD | 1,261,000USD | 1,507,000USD | 940,000USD | 1,171,000USD | 759,000USD |
| Property Plant Equipment Net | 317,000USD | 342,000USD | 368,000USD | 391,000USD | 408,000USD | 427,000USD | 449,000USD | 469,000USD |
| Property Plant Equipment Gross | 476,000USD | 492,000USD | 507,000USD | 519,000USD | 530,000USD | 541,000USD | 552,000USD | 567,000USD |
| Accumulated Other Comprehensive Income | -26,000USD | 50,000USD | 50,000USD | -14,000USD | 5,000USD | 23,000USD | 81,000USD | -51,000USD |
| Common Stock Shares Outstanding | 53,793,490shares | 46,980,777shares | 49,630,119shares | 42,957,619shares | 42,843,938shares | 42,818,660shares | 42,751,577shares | 38,068,378shares |
| Non Current Assets Total | 717,000USD | 742,000USD | 823,999USD | 391,000USD | 1,408,000USD | 1,735,000USD | 1,757,000USD | 1,777,000USD |
| Non Current Liabilities Total | 97,000USD | 128,000USD | 157,000USD | 184,000USD | 211,000USD | 237,000USD | 263,000USD | 288,000USD |
| Non Currrent Assets Other | 400,000USD | 400,000USD | 455,999USD | — | 1,000,000USD | 1,308,000USD | 1,308,000USD | 1,308,000USD |
| Net Working Capital | 46,615,000USD | 55,497,000USD | 50,955,000USD | 26,963,000USD | 32,757,000USD | 39,220,000USD | 46,470,000USD | 51,926,000USD |
| Unclassified Equity | 230,071,000USD | 228,829,000USD | 215,600,000USD | 182,592,000USD | 181,658,000USD | 180,697,000USD | 179,985,000USD | 179,294,000USD |
| Long Term Investments | — | — | — | — | 1,000,000USD | — | — | — |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 61,371,000USD | 46,345,000USD | 54,160,000USD | 34,395,000USD | 45,551,000USD | 28,095,000USD | 9,053,000USD | 18,339,000USD |
| Other Current Assets | 481,000USD | 227,000USD | 411,000USD | 251,000USD | 327,000USD | 414,000USD | 135,000USD | 369,000USD |
| Total Liab | 5,260,000USD | 5,627,000USD | 3,103,000USD | 2,568,000USD | 1,527,000USD | 2,081,000USD | 1,436,000USD | 1,314,000USD |
| Total Stockholder Equity | 56,111,000USD | 40,718,000USD | 51,057,000USD | 31,827,000USD | 44,024,000USD | 26,014,000USD | 7,617,000USD | 17,025,000USD |
| Other Current Liab | 3,545,000USD | 4,347,000USD | 1,777,000USD | 1,365,000USD | 966,000USD | 864,000USD | 1,076,000USD | 774,000USD |
| Capital Stock | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Retained Earnings | -172,768,000USD | -140,002,000USD | -115,558,000USD | -96,177,000USD | -82,501,000USD | -68,909,000USD | -56,617,000USD | -45,968,000USD |
| Cash | 15,647,000USD | 3,025,000USD | 4,543,000USD | 4,728,000USD | 4,707,000USD | 7,409,000USD | 3,883,000USD | 16,823,000USD |
| Cash And Short Term Investments | 59,890,000USD | 44,147,000USD | 52,895,000USD | 33,502,000USD | 45,112,000USD | 27,507,000USD | 7,878,000USD | 16,823,000USD |
| Total Current Assets | 60,629,000USD | 44,610,000USD | 53,675,000USD | 33,835,000USD | 45,439,000USD | 27,921,000USD | 8,836,000USD | 17,972,000USD |
| Total Current Liabilities | 5,132,000USD | 5,390,000USD | 2,786,000USD | 2,168,000USD | 1,524,000USD | 2,028,000USD | 1,318,000USD | 1,296,000USD |
| Net Debt | -15,407,000USD | -2,685,000USD | -4,143,000USD | -4,259,000USD | -4,655,000USD | -7,291,000USD | -3,705,000USD | -16,800,000USD |
| Short Term Debt | 112,000USD | 103,000USD | 83,000USD | 69,000USD | 49,000USD | 65,000USD | 60,000USD | 5,000USD |
| Short Long Term Debt Total | 240,000USD | 340,000USD | 400,000USD | 469,000USD | 52,000USD | 118,000USD | 178,000USD | 23,000USD |
| Short Term Investments | 44,243,000USD | 41,122,000USD | 48,352,000USD | 28,774,000USD | 40,405,000USD | 20,098,000USD | 3,995,000USD | 0USD |
| Net Receivables | 258,000USD | 236,000USD | 369,000USD | 82,000USD | 130,000USD | 340,000USD | 823,000USD | 646,000USD |
| Accounts Payable | 1,475,000USD | 940,000USD | 926,000USD | 734,000USD | 509,000USD | 1,099,000USD | 182,000USD | 483,000USD |
| Property Plant Equipment Net | 342,000USD | 427,000USD | 485,000USD | 560,000USD | 112,000USD | 174,000USD | 217,000USD | 96,000USD |
| Property Plant Equipment Gross | 492,000USD | 541,000USD | 585,000USD | 560,000USD | 179,000USD | 174,000USD | 217,000USD | 96,000USD |
| Accumulated Other Comprehensive Income | 50,000USD | 23,000USD | 6,000USD | -74,000USD | -51,000USD | -2,000USD | 2,000USD | -24,000USD |
| Common Stock Shares Outstanding | 46,980,777shares | 40,404,681shares | 32,566,723shares | 26,443,067shares | 20,773,399shares | 15,680,320shares | 11,987,696shares | 7,743,520shares |
| Non Current Assets Total | 742,000USD | 1,735,000USD | 485,000USD | 560,000USD | 112,000USD | 174,000USD | 217,000USD | 367,000USD |
| Non Current Liabilities Total | 128,000USD | 237,000USD | 317,000USD | 400,000USD | 3,000USD | 53,000USD | 117,999USD | 18,000USD |
| Non Currrent Assets Other | 400,000USD | 1,308,000USD | -1USD | — | -40,405,000USD | 100,000USD | 217,000USD | 271,000USD |
| Net Working Capital | 55,497,000USD | 39,220,000USD | 50,889,000USD | 31,667,000USD | 43,915,000USD | 25,893,000USD | 7,518,000USD | 16,676,000USD |
| Unclassified Equity | 228,829,000USD | 180,697,000USD | 166,609,000USD | 128,078,000USD | 126,576,000USD | 94,925,000USD | 64,232,000USD | 63,017,000USD |
| Other Assets | — | — | 1USD | — | — | 100,000USD | — | 0USD |
| Inventory | — | — | — | — | 113,000USD | 10,000USD | 88,000USD | 0USD |
| Net Tangible Assets | — | — | — | — | 44,024,000USD | 26,014,000USD | 7,617,000USD | 17,025,000USD |
| Current Deferred Revenue | — | — | — | — | — | 8,000USD | — | 34,000USD |
| Non Current Liabilities Other | — | — | — | — | — | 53,000USD | 118,000USD | 0USD |
| Intangible Assets | — | — | — | — | — | — | — | 0USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 0USD |
| Common Stock | — | — | — | — | — | — | — | 0USD |
| Other Liab | — | — | — | — | — | — | — | 0USD |
| Good Will | — | — | — | — | — | — | — | 0USD |
| Short Long Term Debt | — | — | — | — | — | — | — | 0USD |
| Long Term Debt | — | — | — | — | — | — | — | 0USD |
| Long Term Investments | — | — | — | — | — | — | — | 0USD |
| Accumulated Depreciation | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -10,042,000USD | -8,740,000USD | -8,620,000USD | -7,699,000USD | -7,707,000USD | -7,900,000USD | -6,274,000USD | -5,119,000USD |
| Depreciation | 11,000USD | 20,000USD | 18,000USD | 3,000USD | 11,000USD | 11,000USD | 10,000USD | 10,000USD |
| Stock Based Compensation | 822,000USD | 1,192,000USD | 1,016,000USD | 771,000USD | 867,000USD | 589,000USD | 565,000USD | 443,000USD |
| Other Non Cash Items | 654,000USD | -240,000USD | 712,106USD | -160,000USD | -241,000USD | -311,000USD | -346,000USD | -300,000USD |
| Change To Account Receivables | -43,000USD | 2,000USD | -100,734USD | 92,000USD | -17,000USD | 54,000USD | 101,000USD | 8,000USD |
| Change In Working Capital | 295,000USD | 3,000USD | 1,285,032USD | -513,000USD | -79,000USD | 1,177,000USD | 1,575,000USD | 447,000USD |
| Total Cash From Operating Activities | -9,082,000USD | -7,765,000USD | -6,604,860USD | -7,598,000USD | -7,149,000USD | -6,434,000USD | -4,470,000USD | -4,519,000USD |
| Capital Expenditures | -8,000USD | -6,000USD | -16,189USD | -6,000USD | -12,000USD | -7,000USD | -9,000USD | -68USD |
| Free Cash Flow | -9,090,000USD | -7,771,000USD | -6,621,050USD | -7,604,000USD | -7,161,000USD | -6,441,000USD | -4,479,000USD | -4,519,000USD |
| Investments | -2,106,000USD | 8,001,000USD | -25,766,000USD | 8,957,000USD | 6,622,000USD | 5,205,000USD | -5,585,000USD | 4,736,000USD |
| Total Cashflows From Investing Activities | -2,114,000USD | 7,995,000USD | -26,205,409USD | 8,957,000USD | 6,622,000USD | 5,205,000USD | -5,585,000USD | 4,736,000USD |
| Net Borrowings | -3,000USD | -2,000USD | -3,000USD | -2,000USD | -3,000USD | -3,000USD | -3,000USD | — |
| Total Cash From Financing Activities | 417,000USD | 12,091,000USD | 32,012,062USD | 161,000USD | 91,000USD | 120,000USD | 123,000USD | 11,752,000USD |
| Change In Cash | -10,779,000USD | 12,321,000USD | -783,000USD | 1,520,000USD | -436,000USD | -1,109,000USD | -9,932,000USD | 11,969,000USD |
| Begin Period Cash Flow | 15,647,000USD | 3,326,000USD | 4,109,000USD | 2,589,000USD | 3,025,000USD | 4,134,000USD | 14,066,000USD | 2,097,000USD |
| End Period Cash Flow | 4,868,000USD | 15,647,000USD | 3,326,000USD | 4,109,000USD | 2,589,000USD | 3,025,000USD | 4,134,000USD | 14,066,000USD |
| Other Cashflows From Financing Activities | 417,000USD | 458,185USD | -462,938USD | 163,000USD | 94,000USD | 123,000USD | 126,000USD | 11,754,000USD |
| Issuance Of Capital Stock | — | 11,755,000USD | 31,527,000USD | — | — | 0USD | 0USD | — |
| Unclassified Operating Cash Flow | — | — | -1,015,998USD | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | -439USD | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -32,766,000USD | -24,444,000USD | -19,381,000USD | -13,676,000USD | -13,592,000USD | -12,292,000USD | -10,649,000USD | -5,734,000USD |
| Depreciation | -899,000USD | 39,000USD | 30,000USD | 25,000USD | 24,000USD | 21,000USD | 21,000USD | 15,000USD |
| Stock Based Compensation | 3,846,000USD | 2,085,000USD | 1,683,000USD | 1,502,000USD | 1,558,000USD | 1,843,000USD | 1,164,000USD | 620,000USD |
| Other Non Cash Items | 82,000USD | -1,268,000USD | -1,153,000USD | 53,000USD | 219,000USD | 48,000USD | -25,000USD | 39,000USD |
| Change To Account Receivables | -22,000USD | 133,000USD | -287,000USD | 48,000USD | 210,000USD | 483,000USD | -43,000USD | -700,000USD |
| Change In Working Capital | 675,000USD | 1,512,000USD | 93,000USD | 585,000USD | -461,000USD | 1,195,000USD | 387,000USD | -636,000USD |
| Total Cash From Operating Activities | -29,062,000USD | -22,076,000USD | -18,728,000USD | -11,511,000USD | -12,252,000USD | -9,185,000USD | -9,102,000USD | -5,696,000USD |
| Capital Expenditures | -40,000USD | -25,000USD | -24,000USD | -81,000USD | -22,000USD | -47,000USD | -2,000USD | -50,000USD |
| Free Cash Flow | -29,102,000USD | -22,101,000USD | -18,752,000USD | -11,592,000USD | -12,274,000USD | -9,232,000USD | -9,104,000USD | -5,746,000USD |
| Investments | -2,152,000USD | 8,564,000USD | -19,699,000USD | 11,538,000USD | -20,517,000USD | -16,103,000USD | -3,919,000USD | -50,000USD |
| Total Cashflows From Investing Activities | -2,192,000USD | 8,564,000USD | -18,299,000USD | 11,538,000USD | -20,537,000USD | -16,134,000USD | -3,908,000USD | -50,000USD |
| Net Borrowings | -10,000USD | -9,000USD | -6,000USD | -6,000USD | -6,000USD | -5,000USD | -5,000USD | -5,000USD |
| Total Cash From Financing Activities | 43,876,000USD | 11,994,000USD | 36,842,000USD | -6,000USD | 30,087,000USD | 28,845,000USD | 70,000USD | 21,216,000USD |
| Issuance Of Capital Stock | 43,282,000USD | 11,747,000USD | 36,848,000USD | -18,000USD | 29,849,000USD | 28,805,000USD | 7,682,000USD | 20,566,000USD |
| Change In Cash | 12,622,000USD | -1,518,000USD | -185,000USD | 21,000USD | -2,702,000USD | 3,526,000USD | -12,940,000USD | 15,470,000USD |
| Begin Period Cash Flow | 3,025,000USD | 4,543,000USD | 4,728,000USD | 4,707,000USD | 7,409,000USD | 3,883,000USD | 16,823,000USD | 1,353,000USD |
| End Period Cash Flow | 15,647,000USD | 3,025,000USD | 4,543,000USD | 4,728,000USD | 4,707,000USD | 7,409,000USD | 3,883,000USD | 16,823,000USD |
| Other Cashflows From Financing Activities | -400,000USD | 256,000USD | -18,299,000USD | 0USD | 244,000USD | 45,000USD | 75,000USD | 650,000USD |
| Unclassified Financing Cash Flow | 1,004,000USD | — | 18,299,000USD | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | 1,424,000USD | — | — | — | — | — |
| Change To Inventory | — | — | — | -48,000USD | -210,000USD | -483,000USD | — | -372,000USD |
| Change To Liabilities | — | — | — | 0USD | -590,000USD | 651,000USD | -75,000USD | 372,000USD |
| Other Cashflows From Investing Activities | — | — | — | 11,619USD | 2,000USD | 16,000USD | 13,000USD | 0USD |
| Sale Purchase Of Stock | — | — | — | — | — | 28,850,161USD | 75,000USD | 21,216,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 3,526,000USD | -12,940,000USD | 15,470,000USD |
| Dividends Paid | — | — | — | — | — | — | — | 0USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.